Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes (Q37532095)

20 August 2017

Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes (English)

1 reference

20 August 2017

0 references

0 references

0 references

1 reference

H J Lambers Heerspink

1

1 reference

20 August 2017

D de Zeeuw

2

1 reference

20 August 2017

L Wie

3

1 reference

20 August 2017

B Leslie

4

1 reference

20 August 2017

J List

5

1 reference

20 August 2017

5 June 2013

1 reference

Diabetes, Obesity and Metabolism

20 August 2017

1 reference

20 August 2017

15

1 reference

20 August 2017

9

1 reference

20 August 2017

853-862

1 reference

Renal sodium-glucose transport: role in diabetes mellitus and potential clinical implications

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906841

Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906841

Direct cardiac actions of erythropoietin (EPO): effects on cardiac contractility, BNP secretion and ischaemia/reperfusion injury

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906841

Glomerular hyperfiltration and the salt paradox in early [corrected] type 1 diabetes mellitus: a tubulo-centric view.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906841

Tubular sodium handling and tubuloglomerular feedback in experimental diabetes mellitus

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906841

A Simple Method for the Determination of Glomerular Filtration Rate

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906841

Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906841

Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906841

Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906841

Composite renal endpoints: was ACCOMPLISH accomplished?

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906841

Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906841

Dapagliflozin, a novel SGLT2 inhibitor, induces dose-dependent glucosuria in healthy subjects

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906841

Comparison of fixed-dose rosiglitazone/metformin combination therapy with sulphonylurea plus metformin in overweight individuals with Type 2 diabetes inadequately controlled on metformin alone

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906841

Effect on glycemic control of the addition of 2.5 mg glipizide GITS to metformin in patients with T2DM.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906841

Precision of plasma clearance of iohexol for estimation of GFR in patients with renal disease.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906841

Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption

2 September 2018

1 reference

12 December 2020

Impaired autoregulation of GFR in hypertensive non-insulin dependent diabetic patients

1 reference

12 December 2020

Effect of postural change on urine volume and urinary sodium excretion in diabetic nephropathy

1 reference

12 December 2020

Hemodynamic and hypotensive effects of long-term therapy with chlorothiazide

1 reference

12 December 2020

Effect of thiazide diuretics on plasma volume, body electrolytes, and excretion of aldosterone in hypertension

1 reference

12 December 2020

Identifiers

DOI

10.1111/DOM.12127

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

23668478

1 reference